Less chemotherapy is as effective at controlling disease for elderly or frail patients with advanced cancer of the stomach or oesophagus (food pipe), and leads to fewer side effects such as diarrhoea and lethargy. These are the results of a Cancer Research UK funded study, presented prior to the ASCO…...
Transgender women have increased risk of breast cancer compared to cisgender men
Transgender women undergoing hormone treatment have an increased risk of breast cancer compared to cisgender men, new research suggests. According to a study carried out by researchers from the University Medical Centre in Amsterdam, trans women (individuals assigned male sex at birth who identify as women) are around 47 times more likely…...
Skin and breast cancer drugs approved for NHS use in Scotland
Two cancer drugs have been approved for patients on the NHS in Scotland. An immunotherapy for some people with advanced skin cancer and a targeted drug for some patients with breast cancer got the green light this week. Pembrolizumab (Keytruda) will now be an option for patients whose melanoma has spread to the…...
Cancer Research UK to test targeted drug in pancreatic cancer
A dual kinase inhibitor* is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine as part of Cancer Research UK’s Combinations Alliance. The novel combination of drugs targets the process of nerve invasion, observed in over 80% of pancreatic ductal adenocarcinoma (PDAC) and is associated with tumour spread and…...
Cancer drug approved for NHS use in England gives some multiple myeloma patients another option
A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment. They say the decision will benefit approximately 2,100 patients a year. Read more at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2019-05-17-cancer-drug-approved-for-nhs-use-in-england-gives-some-multiple-myeloma-patients-another-option...
Bowel cancer rates are rising in young adults, but do we know what’s behind the increase?
Bowel cancer rates are increasing in adults aged between 20 and 50, according to data from 2 big studies published this week. Both studies looked at large numbers of people across several countries, including the UK, providing strong evidence on the number of people developing bowel cancer. And some worrying trends emerged.…...
News digest – bowel cancer rates, brain tumour ‘pink drink’, cigarette displays and chewing gum
Grace Li New from News Digest this week: follow with new breakthroughs and research on bowel cancer rates, brain tumor “pink drink”, cigarette displays and chewing gum. Read more at: https://scienceblog.cancerresearchuk.org/2019/05/18/news-digest-bowel-cancer-rates-brain-tumour-pink-drink-cigarette-displays-and-chewing-gum/...
Support Cancer Research
Our tireless fight against cancer is nothing without you. You see, we rely almost exclusively on the individual generosity of people like you for the dollars to fund our innovative cancer research programs. AFCR does not accept government grants or rely on pharmaceutical corporate dollars to fund our cutting-edge science…...
AFCR Scientific Advisory Board Chairman’s Brain Cancer Efforts Recognized
W.K. Alfred Yung, M.D., a brain cancer researcher and chairman of the Asian Fund for Cancer Research’s scientific advisory board, was last week presented with the 3rd Annual SNOChina Award for Outstanding Contributions of International Cooperation by the Chinese Medical Doctor Association’s (CMDA) Society for Neuro-Oncology (SNO). The presentation was…...
Yoga for Insomnia, Anxiety and Socializing in Cancer Patients
A discipline consisting of movements through a sequence of postures in coordination with focused breathing, yoga’s documented benefits include increased flexibility, better strength, lowered blood pressure and the reduced severity of insomnia. Many people attribute recovery from depression and anxiety to the regular practice of yoga. Could its practice be…...
